NEW YORK (GenomeWeb News) – The Blue Genomics Consortium Chile is providing $17 million in funding to perform genomics-based research into why some Atlantic salmon and trout seem resistant to Caligus and Salmon Rickettsial Syndrome (SRS).

Chilean government organization Corporation for Production Development (CORFO) last year approved $7.9 million to the project, which includes four partners, AquaGen Norway, Chile AquaGen, German vaccine production firm Vaxxinova, and Norwegian company BioBank.